We are live on ! Find out more
GNOM icon

Global X Genomics & Biotechnology ETF
GNOM

64 hedge funds and large institutions have $138M invested in Global X Genomics & Biotechnology ETF in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

14% more capital invested

Capital invested by funds: $121M → $138M (+$17.4M)

0.95% more ownership

Funds ownership: 15.88% → 16.84% (+0.95%)

2% less funds holding

Funds holding: 65 → 64 (-1)

10% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 10

Holders
64
Holders Change
-1
Holders Change %
-1.54%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
15
Closed
10
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$10M
2
PFG
Prosperity Financial Group
California
+$2.02M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$795K
4
RJFSA
Raymond James Financial Services Advisors
Florida
+$424K
5
IWM
IHT Wealth Management
Illinois
+$302K

Top Sellers

Rank Fund Capital Flow
1
MIG
McGuire Investment Group
Rhode Island
-$2.03M
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$1.64M
3
PAG
Private Advisor Group
New Jersey
-$748K
4
Nomura Asset Management
Nomura Asset Management
Japan
-$639K
5
Jane Street
Jane Street
New York
-$482K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFD
51
Creative Financial Designs
Indiana
$7.98K – – –
MIM
52
Macroview Investment Management
Maryland
$6.62K – – –
GWM
53
Geneos Wealth Management
Colorado
$2.53K – – –
AIP
54
Ahrens Investment Partners
Louisiana
$2.46K +$2.57K +50 New
VWM
55
Venturi Wealth Management
Texas
$2.46K +$2.57K +50 New
RDFA
56
Ritter Daniher Financial Advisory
Ohio
$1.9K – – –
AF
57
Advisornet Financial
Minnesota
$1.87K +$1.96K +38 New
BWP
58
Baldwin Wealth Partners
Massachusetts
$1.85K – – –
Nomura Asset Management
59
Nomura Asset Management
Japan
$1.23K -$639K -12,425 -100%
AF
60
Allworth Financial
California
$1.23K +$1.29K +25 New
BBPWM
61
Blue Bell Private Wealth Management
Pennsylvania
$912 – – –
National Bank of Canada
62
National Bank of Canada
Quebec, Canada
$737 – – –
CFGS
63
Concourse Financial Group Securities
Alabama
$714 – – –
HCM
64
Hollencrest Capital Management
California
$554 – – –
Wells Fargo
65
Wells Fargo
California
$9 – – –
JP Morgan Chase
66
JP Morgan Chase
New York
$2 – – –
Jane Street
67
Jane Street
New York
– -$482K -9,517 Closed
Envestnet Asset Management
68
Envestnet Asset Management
Illinois
– -$205K -4,059 Closed
MML Investors Services
69
MML Investors Services
Massachusetts
– -$198K -3,920 Closed
Citadel Advisors
70
Citadel Advisors
Florida
– -$178K -3,518 Closed
Rockefeller Capital Management
71
Rockefeller Capital Management
New York
– -$116K -2,300 Closed
MCC
72
Money Concepts Capital
Florida
– -$24.6K -486 Closed
CG
73
Cutler Group
California
– -$6K -122 Closed
RIA
74
Realta Investment Advisors
Delaware
– -$1.64K -33 Closed
NA
75
NewEdge Advisors
Louisiana
– -$1.37K -27 Closed
1 2
3
4

GNOM Hedge Fund Activity: Q1 2023 in Review

64 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q1 2023, worth a combined $138M — up 14% from $121M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GNOM and 9 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 19 added.

The largest buyer was Northwestern Mutual Wealth Management, adding an estimated $10M. The largest seller was McGuire Investment Group, cutting an estimated $2.03M.

  • 64 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q1 2023, down from 65 in Q4 2022.
  • Funds reported $138M of Global X Genomics & Biotechnology ETF stock for Q1 2023, up 14% quarter-over-quarter.
  • 9 funds opened new Global X Genomics & Biotechnology ETF positions in Q1 2023 and 10 closed out, a net change of -1 holder.
  • The largest Global X Genomics & Biotechnology ETF buyer in Q1 2023 was Northwestern Mutual Wealth Management, an estimated $10M added.
  • The largest Global X Genomics & Biotechnology ETF seller in Q1 2023 was McGuire Investment Group, an estimated $2.03M sold.

Based on aggregated 13F filings for Q1 2023.